We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACNT icon
3001
Ascent Industries
ACNT
$141M
$263K ﹤0.01%
20,334
SPRO icon
3002
Spero Therapeutics
SPRO
$71.2M
$262K ﹤0.01%
27,226
ESCA icon
3003
Escalade
ESCA
$294M
$261K ﹤0.01%
26,551
HOOK
3004
DELISTED
HOOKIPA Pharma
HOOK
$261K ﹤0.01%
+2,132
New +$181K
AMPY icon
3005
Amplify Energy
AMPY
$172M
$260K ﹤0.01%
39,231
+11,998
+44% +$77.2K
FLNT
3006
Fluent
FLNT
$127M
$256K ﹤0.01%
17,031
ABEO icon
3007
Abeona Therapeutics
ABEO
$425M
$255K ﹤0.01%
3,111
FTK icon
3008
Flotek Industries
FTK
$1.36B
$255K ﹤0.01%
21,200
GCBC icon
3009
Greene County Bancorp
GCBC
$584M
$254K ﹤0.01%
17,614
+1,544
+10% +$21.6K
PACD
3010
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$254K ﹤0.01%
62,142
STRO icon
3011
Sutro Biopharma
STRO
$423M
$249K ﹤0.01%
2,259
PRVL
3012
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$248K ﹤0.01%
15,662
ELVT
3013
DELISTED
Elevate Credit, Inc.
ELVT
$245K ﹤0.01%
54,925
AIRG icon
3014
Airgain
AIRG
$71.7M
$243K ﹤0.01%
22,662
STEX
3015
Streamex Corp
STEX
$82.5M
$243K ﹤0.01%
4,098
PRGX
3016
DELISTED
PRGX Global, Inc.
PRGX
$241K ﹤0.01%
48,956
PVBC
3017
DELISTED
Provident Bancorp
PVBC
$238K ﹤0.01%
19,099
+1
+0% +$12
MGI
3018
DELISTED
MoneyGram International, Inc. New
MGI
$237K ﹤0.01%
112,841
-13,178
-10% -$42.3K
USX
3019
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$233K ﹤0.01%
46,159
CFMS
3020
DELISTED
Conformis, Inc. Common Stock
CFMS
$233K ﹤0.01%
6,198
PHAS
3021
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$225K ﹤0.01%
36,799
EYPT icon
3022
EyePoint Inc
EYPT
$1.13B
$223K ﹤0.01%
14,341
III icon
3023
Information Services Group
III
$251M
$223K ﹤0.01%
88,088
ALOT icon
3024
AstroNova
ALOT
$226M
$222K ﹤0.01%
16,119
-14,236
-47% -$217K
BTAI icon
3025
BioXcel Therapeutics
BTAI
$28.7M
$221K ﹤0.01%
943
+159
+20% +$16K

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.